Content about New Drugs & OTCs

August 8, 2011

Boston Therapeutics is seeking approval for a generic version of a pill for Type 2 diabetes, the drug maker said.

August 8, 2011

The Food and Drug Administration has accepted an approval application for a drug made by Teva Pharmaceutical Industries for treating allergies, Teva said.

August 4, 2011

The world's top-selling drug may become available over the counter, if its manufacturer has its way, according to published reports.

August 4, 2011

GlaxoSmithKline company Stiefel announced it is seeking approval for a facial acne treatment in patients ages 12 years and older.

August 3, 2011

Topco, a member-owned cooperative serving the food industry, recently kicked off an initiative substituting its TopCare-branded over-the-counter medicines for the equivalent prescription pharmaceutical, where appropriate, in an effort to save patient dollars and promote the TopCare brand.

August 2, 2011

Generic drug maker Amneal has introduced four new drugs to the market, all available in tablet form.

August 2, 2011

In an effort to bring faster relief to the millions of consumers who suffer from tooth sensitivity, Colgate-Palmolive has developed the new Colgate Sensitive Pro-Relief toothpaste.

August 2, 2011

The Food and Drug Administration has approved a new use for a drug made by Novartis for treating multiple sclerosis, the Swiss drug maker's U.S. subsidiary said Monday.

August 2, 2011

The Food and Drug Administration has given tentative approval to an emergency treatment for severe allergic reactions made by Intelliject, the drug maker said.

August 2, 2011

Kinney Drugs will provide flu immunizations to patients by appointment during the 2011-2012 flu season.

August 2, 2011

The Food and Drug Administration has granted orphan drug designation to a chemotherapy drug made by Merrimack Pharmaceuticals for pancreatic cancer, the drug maker said Monday.

August 2, 2011

NeoStrata, which markets and develops therapeutic and cosmetic dermatological products, is aiming to supercharge skin care with four new targeted serums available at Ulta and select online beauty retailers.

August 1, 2011

The Food and Drug Administration has approved a drug made by Bristol-Myers Squibb for injection under the skin to treat rheumatoid arthritis, Bristol said Friday.

August 1, 2011

The Food and Drug Administration has approved a generic version of a short-term adjunct treatment for obesity.

July 29, 2011

EyeScience on Thursday introduced a new eye vitamin for those who spend their work day staring at a computer screen in an effort to help prevent and alleviate vision problems associated with computer vision syndrome.

July 29, 2011

Prestige Brands on Thursday announced the launch of its new PediaCare and Little Remedies single-concentration acetaminophen products.

July 29, 2011

PharmaCline on Thursday announced it has secured the worldwide rights for drug delivery technology and existing antibiotic products from Phillips Co. that will enable production of a well-tolerated and broad-spectrum topical antibiotic.

July 29, 2011

The Food and Drug Administration has approved a generic drug for diabetes made by Indian generic drug maker Strides Arcolab.

July 29, 2011

Teva Pharmaceuticals has launched an authorized generic version of a contraceptive made by Duramed Pharmaceuticals, Teva said.

July 28, 2011

Generic drug maker Watson Pharmaceuticals has launched a generic version of a contraceptive made by Duramed Pharmaceuticals, Watson said Thursday.

July 26, 2011

The branded drugs division of Impax Labs has finished enrolling patients in a late-stage trial of a drug for Parkinson’s disease.

July 26, 2011

Japanese drug maker Takeda Pharmaceutical is reapplying for approval of two drugs to treat Type 2 diabetes after the Food and Drug Administration turned down its last applications, the company said.

July 22, 2011

Perrigo on Thursday announced that it has received approval from the Food and Drug Administration to market a cinnamon-flavored, over-the-counter coated nicotine polacrilex gum USP in 2-mg and 4-mg strengths.

July 21, 2011

The Food and Drug Administration has approved a drug made by AstraZeneca to reduce the rate of heart attacks in patients with acute coronary syndrome, the Anglo-Swedish drug maker said.

© 2014 Drug Store News. All Rights Reserved.